Brightman Diana, Shinwari Nawaal, Porollo Aleksey, Dosunmu Eniolami O, Ullah Ehsan, Guan Bin, Hufnagel Robert B, Brooks Brian P, Blain Delphine, Fuhrmann Sabine, Simpson Brittany, Slavotinek Anne M
Division of Human Genetics, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Clin Genet. 2025 May 15. doi: 10.1111/cge.14768.
We present a 2-year-old male with bilateral iris and chorioretinal colobomas, speech delays, and facial and digital anomalies. Trio exome sequencing demonstrated a de novo, novel heterozygous variant, c.379G>A p.Glu127Lys in CDC42, conferring a diagnosis of Takenouchi-Kosaki syndrome. The p.Glu127Lys variant was not located in the same region as previously designated mutation classes for CDC42, and the patient's missense substitution was predicted to disrupt CDC42 interactions with Collybistin II and IQGAP1. As conditional knock-out mouse models have demonstrated coloboma in association with loss of Cdc42 expression, we conclude that the colobomas can be attributed to the CDC42 variant and that similar ocular anomalies are likely to be described with other Rho GTPases in the future.
我们报告了一名2岁男性,患有双侧虹膜和脉络膜视网膜缺损、语言发育迟缓以及面部和手部异常。三联体全外显子测序显示在CDC42基因中存在一个新生的、新的杂合变异,即c.379G>A p.Glu127Lys,从而确诊为竹内-小崎综合征。p.Glu127Lys变异并不位于先前为CDC42指定的突变类别所在的同一区域,并且预测该患者的错义替代会破坏CDC42与Collybistin II和IQGAP1的相互作用。由于条件性敲除小鼠模型已证明与Cdc42表达缺失相关的缺损,我们得出结论,这些缺损可归因于CDC42变异,并且未来可能会用其他Rho GTPases描述类似的眼部异常。